Sjoerd Schetters

3.4k total citations
22 papers, 1.8k citations indexed

About

Sjoerd Schetters is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sjoerd Schetters has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Sjoerd Schetters's work include Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (6 papers) and T-cell and B-cell Immunology (5 papers). Sjoerd Schetters is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (6 papers) and T-cell and B-cell Immunology (5 papers). Sjoerd Schetters collaborates with scholars based in Netherlands, United Kingdom and United States. Sjoerd Schetters's co-authors include Yvette van Kooyk, Diego Gómez‐Nicola, Ernesto Rodríguez, Juan J. García‐Vallejo, V. Hugh Perry, Mariana Vargas‐Caballero, Adrián Olmos‐Alonso, Sarmi Sri, Renzo Mancuso and Katharine E. Askew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature reviews. Immunology.

In The Last Decade

Sjoerd Schetters

22 papers receiving 1.8k citations

Peers

Sjoerd Schetters
Leonid Tarassishin United States
Sjoerd Schetters
Citations per year, relative to Sjoerd Schetters Sjoerd Schetters (= 1×) peers Leonid Tarassishin

Countries citing papers authored by Sjoerd Schetters

Since Specialization
Citations

This map shows the geographic impact of Sjoerd Schetters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sjoerd Schetters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sjoerd Schetters more than expected).

Fields of papers citing papers by Sjoerd Schetters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sjoerd Schetters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sjoerd Schetters. The network helps show where Sjoerd Schetters may publish in the future.

Co-authorship network of co-authors of Sjoerd Schetters

This figure shows the co-authorship network connecting the top 25 collaborators of Sjoerd Schetters. A scholar is included among the top collaborators of Sjoerd Schetters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sjoerd Schetters. Sjoerd Schetters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolk, Dorian A., Sjoerd Schetters, Eelco D. Keuning, et al.. (2024). Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics. 16(5). 581–581. 2 indexed citations
2.
Patente, Thiago A., Maaike R. Scheenstra, Arifa Ozir‐Fazalalikhan, et al.. (2024). S. mansoni -derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration. PLoS Pathogens. 20(8). e1012457–e1012457. 3 indexed citations
3.
Goede, Kyra E. de, Sanne G. S. Verberk, Jeroen Baardman, et al.. (2021). Myeloid-Specific Acly Deletion Alters Macrophage Phenotype In Vitro and In Vivo without Affecting Tumor Growth. Cancers. 13(12). 3054–3054. 6 indexed citations
4.
Rodríguez, Ernesto, Kelly Boelaars, Kari Brown, et al.. (2021). Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nature Communications. 12(1). 1270–1270. 191 indexed citations
5.
Schetters, Sjoerd & Martijn J. Schuijs. (2021). Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum. Frontiers in Immunology. 12. 772004–772004. 5 indexed citations
6.
Stolk, Dorian A., Sophie K. Horrevorts, Sjoerd Schetters, et al.. (2021). Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition. Molecular Therapy — Oncolytics. 21. 315–328. 9 indexed citations
7.
Schetters, Sjoerd, Laura Kruijssen, Steef Engels, et al.. (2020). Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity. Biomaterials. 262. 120342–120342. 9 indexed citations
8.
Hofland, Tom, Anne W. J. Martens, Renate de Boer, et al.. (2020). Human CXCR5 + PD‐1 + CD8 T cells in healthy individuals and patients with hematologic malignancies. European Journal of Immunology. 51(3). 703–713. 10 indexed citations
9.
Crommentuijn, Matheus H. W., Sjoerd Schetters, Sophie A. Dusoswa, et al.. (2020). Immune involvement of the contralateral hemisphere in a glioblastoma mouse model. Journal for ImmunoTherapy of Cancer. 8(1). e000323–e000323. 10 indexed citations
10.
Schetters, Sjoerd, Laura Kruijssen, Matheus H. W. Crommentuijn, et al.. (2020). Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant. The FASEB Journal. 34(9). 12406–12418. 15 indexed citations
11.
Schetters, Sjoerd, Wouter S. P. Jong, Sophie K. Horrevorts, et al.. (2019). Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells. Acta Biomaterialia. 91. 248–257. 91 indexed citations
12.
Gruijl, Tanja D. de, et al.. (2019). Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells. Current Opinion in Chemical Biology. 53. 167–172. 10 indexed citations
13.
Rodríguez, Ernesto, Sjoerd Schetters, & Yvette van Kooyk. (2018). The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nature reviews. Immunology. 18(3). 204–211. 319 indexed citations
14.
Schetters, Sjoerd, Diego Gómez‐Nicola, Juan J. García‐Vallejo, & Yvette van Kooyk. (2018). Neuroinflammation: Microglia and T Cells Get Ready to Tango. Frontiers in Immunology. 8. 1905–1905. 262 indexed citations
15.
Schetters, Sjoerd, Laura Kruijssen, Matheus H. W. Crommentuijn, et al.. (2018). Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity. Frontiers in Immunology. 9. 990–990. 38 indexed citations
16.
Veninga, Henrike, Salvador Iborra, Ellen G. F. Borg, et al.. (2018). Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming. Cell Reports. 22(6). 1484–1495. 95 indexed citations
17.
Dusoswa, Sophie A., Sophie K. Horrevorts, Sjoerd Schetters, et al.. (2018). EXTH-21. REPURPOSING GLIOBLASTOMA EXOSOMES AS PERSONALIZED MULTI-ANTIGENIC ANTI-TUMOR VACCINE. Neuro-Oncology. 20(suppl_6). vi89–vi89. 1 indexed citations
18.
Kamphuis, Willem, Lieneke Kooijman, Sjoerd Schetters, Marie Orre, & Elly M. Hol. (2016). Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(10). 1847–1860. 147 indexed citations
19.
Perdicchio, Maurizio, Juan M. Ilarregui, Marleen I. Verstege, et al.. (2016). Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells. Proceedings of the National Academy of Sciences. 113(12). 3329–3334. 134 indexed citations
20.
Olmos‐Alonso, Adrián, Sjoerd Schetters, Sarmi Sri, et al.. (2016). Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology. Brain. 139(3). 891–907. 382 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026